載入...
Effects of levosimendan in patients with acute heart failure and cardiorenal syndrome
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Cardiorenal syndrome (CRS) is common in patients with acute heart failure (AHF) and is associated with poor prognosis. Levosimendan (LVS) is an inodilator used in AHF and has beneficial effects on renal function (RF). However, it...
Na minha lista:
| 發表在: | Eur Heart J Acute Cardiovasc Care |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8264012/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjacc/zuab020.028 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|